139 related articles for article (PubMed ID: 4098945)
1. Levodopa side-effects and the Lesch-Nyhan syndrome.
Proctor P; McGinness JE
Lancet; 1970 Dec; 2(7687):1367. PubMed ID: 4098945
[No Abstract] [Full Text] [Related]
2. The significance of the deficiency state in Lesch-Nyhan disease.
Ghadimi H; Bhalla CK; Kirchenbaum DM
Acta Paediatr Scand; 1970 May; 59(3):233-40. PubMed ID: 5444709
[No Abstract] [Full Text] [Related]
3. The influence of adenine on the clinical features and purine metabolism in the Lesch-Nyhan syndrome.
van der Zee SP; Lommen EJ; Trijbels JM; Schretlen ED
Acta Paediatr Scand; 1970 May; 59(3):259-64. PubMed ID: 5444710
[No Abstract] [Full Text] [Related]
4. Diagnosis of the Lesch-Nyhan syndrome.
Omura GA
JAMA; 1970 Jul; 213(2):301. PubMed ID: 5467911
[No Abstract] [Full Text] [Related]
5. Effect of allopurinol on pyrimidine metabolism in the Lesch-Nyhan syndrome.
Beardmore TD; Fox IH; Kelley WN
Lancet; 1970 Oct; 2(7677):830-1. PubMed ID: 4196060
[No Abstract] [Full Text] [Related]
6. [Pathogenesis of dyspurinia and encephalopathy in Lesh-Nyhan disease].
Paget M; Decouvelaere-Lefèvre MF
J Sci Med Lille; 1970; 88(6):363-72. PubMed ID: 5429748
[No Abstract] [Full Text] [Related]
7. The Lesch-Nyhan syndrome.
Dizmang LH; Cheatham CF
Am J Psychiatry; 1970 Nov; 127(5):671-7. PubMed ID: 5491543
[No Abstract] [Full Text] [Related]
8. [From Lesch-Nyhan disease to primary gout].
Ryckewaert A; Audeval B; Kuntz D
Rev Eur Etud Clin Biol; 1970; 15(6):605-9. PubMed ID: 4919604
[No Abstract] [Full Text] [Related]
9. Alteration of purine control mechanisms in patients with the Lesch-Nyhan mutation.
Benke PJ
Wis Med J; 1971 Jul; 70(7):174-5. PubMed ID: 5560233
[No Abstract] [Full Text] [Related]
10. Lesch-Nyhan syndrome: preventive control.
Seegmiller JE
Science; 1970 Dec; 170(3964):1333. PubMed ID: 5529524
[No Abstract] [Full Text] [Related]
11. [Action of uricosuric, uricolytic agents and enzymatic inhibitors on dyspurinia in Lesh-Myhan disease].
Paget M; Decouvelaere-Lefèvre MF
J Sci Med Lille; 1970; 88(6):373-80. PubMed ID: 5450291
[No Abstract] [Full Text] [Related]
12. Inborn terror of metabolism.
Vaisrub S
JAMA; 1970 Dec; 214(12):2186-7. PubMed ID: 5536584
[No Abstract] [Full Text] [Related]
13. [Treatment of congenital purine-pyrimidine metabolism anomalies].
Wada Y
Horumon To Rinsho; 1971 Jan; 19(1):16-22. PubMed ID: 4926455
[No Abstract] [Full Text] [Related]
14. [Congenital disorder of purine metabolism].
Wada Y
Nihon Rinsho; 1970 May; 28(5):1550-76. PubMed ID: 4916331
[No Abstract] [Full Text] [Related]
15. Lesch-Nyhan syndrome: altered kinetic properties of mutant enzyme.
McDonald JA; Kelley WN
Science; 1971 Feb; 171(3972):689-91. PubMed ID: 4322125
[TBL] [Abstract][Full Text] [Related]
16. The urinary excretion of aminoimidazolecarboxamide in the Lesch-Nyhan syndrome.
Newcombe DS
Pediatrics; 1970 Oct; 46(4):508-12. PubMed ID: 5503686
[No Abstract] [Full Text] [Related]
17. Biochemically marked lymphocytoid lines: establishment of Lesch-Nyhan cells.
Choi KW; Bloom AD
Science; 1970 Oct; 170(3953):89-90. PubMed ID: 5452899
[TBL] [Abstract][Full Text] [Related]
18. Detection of females heterozygous for the Lesch-Nyhan mutation by 8-azaguanine-resistant growth of cultured fibroblasts.
Felix JS; DeMars R
J Lab Clin Med; 1971 Apr; 77(4):596-604. PubMed ID: 4252001
[No Abstract] [Full Text] [Related]
19. Lesch-Nyhan syndrome.
Arima M; Aoki N; Ono K
Paediatr Univ Tokyo; 1970 Dec; 18():25-31. PubMed ID: 5514644
[No Abstract] [Full Text] [Related]
20. Lesch-Nyhan syndrome: preventive control by prenatal diagnosis.
Boyle JA; Raivio KO; Astrin KH; Schulman JD; Graf ML; Seegmiller JE; Jacobsen CB
Science; 1970 Aug; 169(3946):688-9. PubMed ID: 5464303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
